Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Tenon Medical, Inc. Warrant (TNONW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: TNONW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -44.44% | Avg. Invested days 7 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.01 - 0.09 | Updated Date 02/26/2025 |
52 Weeks Range 0.01 - 0.09 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Tenon Medical, Inc. Warrant
Company Overview
History and Background
Tenon Medical, Inc. is a medical device company focused on transforming spine surgery by providing innovative solutions for the treatment of sacroiliac joint dysfunction. The warrants are derivatives of the underlying stock.
Core Business Areas
- Sacroiliac Joint Fusion: Develops and markets the CATAMARANu2122 SI Joint Fusion System for minimally invasive treatment of sacroiliac joint dysfunction.
Leadership and Structure
The company is led by its CEO and has a typical organizational structure for a medical device company, including departments for R&D, sales, marketing, and operations.
Top Products and Market Share
Key Offerings
- CATAMARANu2122 SI Joint Fusion System: A minimally invasive surgical system designed to stabilize and fuse the sacroiliac joint. Market share data for specific SI joint fusion systems can vary, but the market is competitive. Competitors include SI-BONE (SIBN), Medtronic (MDT), and Globus Medical (GMED).
Market Dynamics
Industry Overview
The sacroiliac joint fusion market is growing due to an aging population and increasing awareness of SI joint dysfunction as a source of lower back pain. The market is competitive and subject to regulatory approvals and reimbursement policies.
Positioning
Tenon Medical aims to be a key player in the SI joint fusion market with its CATAMARAN system. Its competitive advantage may lie in the design and clinical outcomes of its system.
Total Addressable Market (TAM)
The TAM for SI joint fusion is estimated to be in the hundreds of millions of dollars annually. Tenon Medical is positioned to capture a portion of this market through its sales and marketing efforts.
Upturn SWOT Analysis
Strengths
- Innovative CATAMARANu2122 SI Joint Fusion System
- Focus on minimally invasive surgery
- Potential for strong clinical outcomes
Weaknesses
- Limited market share compared to larger competitors
- Dependence on regulatory approvals and reimbursement
- Requires significant capital for sales and marketing
Opportunities
- Growing awareness of SI joint dysfunction
- Increasing adoption of minimally invasive surgery
- Potential for expansion into new markets
Threats
- Competition from larger medical device companies
- Changes in regulatory and reimbursement policies
- Potential for product liability claims
Competitors and Market Share
Key Competitors
- SIBN
- MDT
- GMED
Competitive Landscape
Tenon Medical faces stiff competition from larger players with established market presence and broader product portfolios. The company needs to differentiate itself through innovation, clinical outcomes, and effective marketing.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is tied to Tenon Medical Inc.'s performance in the SI joint fusion market.
Future Projections: Future projections depend on market adoption of the CATAMARAN system and overall growth in the SI joint fusion market. Analyst estimates should be reviewed for the parent company.
Recent Initiatives: Recent initiatives include sales and marketing efforts, R&D for product improvements, and regulatory submissions.
Summary
Tenon Medical, with its associated warrants, is a small player in a growing but competitive market. Its CATAMARAN system offers promise, but it faces challenges from larger, more established companies. Success depends on achieving market share growth, navigating regulatory hurdles, and maintaining financial stability. The company needs to carefully manage its cash flow and invest strategically in sales and marketing to drive adoption of its technology and expand its footprint within the SI joint fusion market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Market research reports
- Analyst reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tenon Medical, Inc. Warrant
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-06-15 | CEO - | ||
Sector Healthcare | Industry Medical Devices | Full time employees 22 | Website |
Full time employees 22 | Website | ||
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.